JO
IPCI

John Overdeck’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

John Overdeck’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-1,050
Closed -$46K – 2453
2014
Q1 		$46K Buy
+1,050
New +$42K ﹤0.01% 1927

Other funds holding IPCI

TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

John Overdeck's IPCI Position: Q2 2014 in Review

John Overdeck sold out of Intellipharmaceuticals International Inc. (IPCI) in Q2 2014, closing a stake of 1,050 shares — an estimated $46K sold.

John Overdeck first reported a position in IPCI in Q1 2014 and held it in 1 quarter. The position peaked at $46K in Q1 2014. 19 funds tracked by Wall St. Rank hold IPCI as of Q2 2014.

  • John Overdeck reported no remaining Intellipharmaceuticals International Inc. position as of Q2 2014 after selling out during the quarter.
  • John Overdeck sold 1,050 Intellipharmaceuticals International Inc. shares in Q2 2014, an estimated $46K.
  • John Overdeck first reported a position in Intellipharmaceuticals International Inc. in Q1 2014 and held it in 1 quarter.
  • John Overdeck's Intellipharmaceuticals International Inc. position peaked at $46K in Q1 2014.
  • 19 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q2 2014.

Based on Two Sigma Investments's 13F filing for Q2 2014, filed 14 Aug 2014.